Saudi Arabia – by many measures the cultural, social, and economic centre of the Arab and Islamic worlds – is currently undergoing a once-in-a-lifetime transformation. The ‘Vision 2030’ transformation plan is not only reshaping the Saudi economy and reducing its…
Despite its diminutive size, Denmark boasts a world-renowned healthcare and life science industry containing both household pharma giants as well as a robust network of academia, a host of niche service providers, and a growing throng of biotech start-ups. With…
On the verge of its 100th anniversary, the Republic of Turkey appears to be approaching a decisive moment in the trajectory of its healthcare industry. With a comprehensive social security system covering over 95 percent of the population already in the bag, and after more…
PharmaBoardroom’s latest report, InFigures: Asia Pacific 2021 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs. Covering everything from population health to market growth, company rankings, innovation footprints, IPOs,…
With outstanding fundamentals, including top-class universities and hospitals, a government cognizant of the benefits that a robust research-based biopharma industry brings, and straightforward business processes, Singapore has long been a hub for life science companies…
Switzerland continues to hold its own as a focal point for innovation and discovery in global medical science and ranks very highly on the radar of both Big Pharma and the international biotech community alike. As well as Switzerland’s continuing relevance to the European…
Become a PharmaBoardroom Member for free to access this contentJoin the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroomRegisterAlready a member? Sign In Log into your account Email…
A bastion of equality with high levels of healthcare spending, excellent research and universities, a global commitment to improving health outcomes, and a deeply entrenched digital footprint, Norway is full of potential as a life sciences investment destination. This…
The inaugural edition of the US Healthcare and Life Sciences Review has collated comments and insights from stakeholders across regulators, health insurers, pharma and biotech companies, as well as patient and industry associations, to provide an incisive snapshot of the US…
InFigures USA is an extensive compilation of data and infographics from the world’s largest and most important pharmaceutical market. US sales of drugs accounted for 48 percent of the global market for pharmaceuticals in 2019 and pharma market spending is on the rise, with…
InFigures MENA is an extensive compilation of the latest country-specific data on economies, healthcare, pharmaceutical industries, and R&D in some of the region’s most dynamic markets. This new 51-page report contains data from Algeria, Egypt, Iran, Morocco, Saudi…
InFigures Asia-Pacific is an extensive compilation of the latest country-specific data on economies, healthcare, pharmaceutical industries, and R&D in some of the region’s most dynamic markets. This new 38-page report contains data from Australia, Hong Kong SAR, Japan,…